Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,111
datasets available to search
ShareScore release 0.9.0
Dataset results
2,111 results for “bevacizumab”
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT00778102. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00484939. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
ClinicalTrials.gov study NCT02456857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02853318. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00130520. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intranasal Bevacizumab for HHT-Related Epistaxis
ClinicalTrials.gov study NCT02389959. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
ClinicalTrials.gov study NCT01931098. IPD Sharing: NO. Countries: 1. Publications: 3.
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
ClinicalTrials.gov study NCT00622726. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
ClinicalTrials.gov study NCT01532089. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovari
ClinicalTrials.gov study NCT01081262. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects Wi
ClinicalTrials.gov study NCT01454102. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT00100815. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
ClinicalTrials.gov study NCT01223235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00121199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
ClinicalTrials.gov study NCT00049322. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT07286695. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00811135. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.
ClinicalTrials.gov study NCT00717405. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
ClinicalTrials.gov study NCT00607113. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
ClinicalTrials.gov study NCT00096278. IPD Sharing: Not stated. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.